TriangleFOR PATIENTS · SOURCE READING
Treatment of Intermediate-Risk Neuroblastoma
Source: Neuroblastoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 23, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
For information about the treatments listed below, see the Treatment Option Overview section.
Source links and citations
Treatment of newly diagnosed intermediate-risk neuroblastoma may include:
Source links and citations
Chemotherapy for children with symptoms or to shrink a tumor that cannot be removed by surgery. Surgery may be done after chemotherapy.
Source links and citations
Surgery alone for infants.
Observation alone for infants.
Source links and citations
Radiation therapy to treat tumors that have continued to grow during treatment with chemotherapy or tumors that cannot be removed by surgery and have continued to grow after treatment with chemotherapy.
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice